Skip to search.
 FTSE 100 Up 0.90%

BioCryst Pharmaceuticals, Inc. (BCRX)

-NasdaqGS
11.42 Up 0.21(1.87%) 28 Aug 21:00
Add to Portfolio
Prev Close:11.21
Open:11.10
Bid:10.51 x 1000
Ask:11.65 x 300
1y Target Est:18.00
Beta:3.58544
Next Earnings Date: 5-Nov-15BCRX Earnings announcement
Day's Range:11.03 - 11.43
52wk Range:7.85 - 16.83
Volume:424,931
Avg Vol (3m):1,032,760
Market Cap:836.39m
P/E (ttm):N/A
EPS (ttm):-0.43
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for BCRX at this time.

Comparison

Symbol% ChgMkt Cap
BCRXUp 1.87%836.39m
GSKUp 0.10%99.70b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):19.85
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.64
Quarterly EPS Est (Sep-15) :-0.22
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):0.79

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small molecule drugs that block key enzymes involved in the pathogenesis of diseases. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback